126 related articles for article (PubMed ID: 6404440)
21. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial.
Xu ZY; Liu CB; Francis DP; Purcell RH; Gun ZL; Duan SC; Chen RJ; Margolis HS; Huang CH; Maynard JE
Pediatrics; 1985 Nov; 76(5):713-8. PubMed ID: 3903646
[TBL] [Abstract][Full Text] [Related]
22. Active immunization of homosexual men using a recombinant hepatitis B vaccine.
Hess G; Rossol S; Voth R; Cheatham-Speth D; Clemens R; Meyer zum Büschenfelde KH
J Med Virol; 1989 Dec; 29(4):229-31. PubMed ID: 2576035
[TBL] [Abstract][Full Text] [Related]
23. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men.
Prinsen H; Goilav C; Safary A; André FE; Piot P
Postgrad Med J; 1987; 63 Suppl 2():147-9. PubMed ID: 3317352
[TBL] [Abstract][Full Text] [Related]
25. Post-exposure hepatitis B vaccination of sexual partners of acute viral hepatitis patients.
Papaevangelou G; Roumeliotou-Karayannis A; Tassopoulos N; Kolaitis N; Contoyannis P; Krugman S
J Infect; 1983 Jul; 7 Suppl 1():63-7. PubMed ID: 6371152
[TBL] [Abstract][Full Text] [Related]
26. [Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
Yan B; Lyu J; Liu J; Feng Y; Xu A; Chen S; Zhou L; Liang X; Cui F; Wang F; Zhang L
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1043-7. PubMed ID: 25619213
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
[TBL] [Abstract][Full Text] [Related]
28. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
[TBL] [Abstract][Full Text] [Related]
29. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
[TBL] [Abstract][Full Text] [Related]
30. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
31. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.
Mahallawi W
Ann Saudi Med; 2018; 38(6):413-419. PubMed ID: 30531175
[TBL] [Abstract][Full Text] [Related]
32. [Results of active preventive vaccination against hepatitis B with a German vaccine].
Henning H; Laufs R; Kätzner K; Bredehorst R
Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
Szmuness W; Stevens CE; Harley EJ; Zang EA; Alter HJ; Taylor PE; DeVera A; Chen GT; Kellner A
N Engl J Med; 1982 Dec; 307(24):1481-6. PubMed ID: 6755247
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
35. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
[TBL] [Abstract][Full Text] [Related]
36. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine.
Halliday ML; Rankin JG; Bristow NJ; Coates RA; Corey PN; Strickler AC
Arch Intern Med; 1990 Jun; 150(6):1195-200. PubMed ID: 2141247
[TBL] [Abstract][Full Text] [Related]
37. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study.
Zuckerman JN; Sabin C; Craig FM; Williams A; Zuckerman AJ
BMJ; 1997 Feb; 314(7077):329-33. PubMed ID: 9040320
[TBL] [Abstract][Full Text] [Related]
38. [Verification of the safety, inoculability, reactogenicity and antigenic properties of a live recombinant smallpox-hepatitis B vaccine in an experiment in volunteers].
Chernos VI; Cheliapov NV; Antonova TP; Rakhilina LE; Unanov SS; Al'tshteĭn AD; Zakharova LG; Fodor II; Bendukidze KA; Komarov FI
Vopr Virusol; 1990; 35(2):132-5. PubMed ID: 2167564
[TBL] [Abstract][Full Text] [Related]
39. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
40. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
